A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

490

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

TAU-284

TAU-284 Low

DRUG

TAU-284

TAU-284 High

DRUG

Placebo

Placebo

Trial Locations (5)

Unknown

Reserch site, Chūbu

Reserch site, Hokuriku

Reserch site, Kanto

Reserch site, Kinki

Reserch site, Kyusyu

All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY